Answers are grounded in this paper and cite their sources.
The use of animal models in Parkinson's disease research has been controversial in terms of how well they relate to the clinical condition and thus their utility for translating therapies from the lab to the clinic. In this article, two researchers debate this issue with Roger Barker taking the view that such models are not useful and may even be misleading, while Anders Björklund defends their use and highlights their value in better understanding and treating this condition.
No takes yet. Share an insight, caveat, or question.
Barker et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: